Body Sensors Market is Rising Rapidly at a Healthy CAGR of 10.74% During Forecast to 2023

 

Body Sensors Market – Overview:

The need for small portable mobile devices that can regularly monitor the vital statistics of individuals have fuelled the growth of the industry. Market reports linked to the healthcare sector along with published reports on other sectors have been lately made available by Market Research Future, which has also published a report on this market.The industry is projected to attain USD 25 billion in revenue while expanding with a CAGR of approximately 10.7 percent in the review period.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1065

Due to the necessity to constantly monitor various bodily parameters, the body sensors market has developed at an increased pace. Improvements in technology and an increased level of research and developed directed towards this industry, have led to emergence of positive cues for the expansion of the Body Temperature  Sensors Market . Amplified awareness and interest for the adoption of wearable technology by individuals is predicted to clearly impact the development of the industry.

Global Competitive Analysis:

The corporate strategy of the competitors in the market is focused currently on capitalizing the dynamic pace of technological innovations which have led to plenty of changes both in terms of product development and handling competition. This particular trend has enabled portfolio improvement along with the affinity for diversification in the sector, which has indirectly enabled the players to use the valuable state of dealings available in this industry. The use of these prospects by contenders, who are trying to cultivate their industry stake by intensive expansion can stimulate the expansion of this industry. The companies are also moreover trying to create and capture financial in a suitable manner. This has elevated the potential for the forthcoming growth period significantly. The strategic decision-making process has increased the productivity of companies so that they maintain their company’s liquidity and sustain feasible to take effective choices in terms of strategy designing and implementation.

The competitors prominent in the Body Sensors Market are Koninklijke Philips N.V. (Netherlands), Althen GmbH Mess (Germany), Amsys GmbH (Germany Balluff GmbH (Germany), Allegro MicroSystems (US), 4B Braime Components Ltd. (UK),), ASC GmbH (Germany), Barksdale GmbH (Germany) and Baumer Group (Switzerland).

 

Industry Segments:

The body sensors industry has been segmented on the basis of types of sensors which comprise of position sensors, motion sensors, temperature sensor, pressure sensor, inertial sensors and other sensors. On the basis of application, the industry is segmented into fitness, temperature monitoring, weight monitoring, inertial sensors, heart rate monitoring and other applications.

Detailed Regional Analysis:

The body sensors industry comprises of four regions such as Americas, Europe, Middle East, Asia-Pacific and Africa.  The North American region is the foremostindustry for the body sensors market. The extensive use of wearable medical devices, continual R&D in the field of medical technology and the demand for smart sensors are fuelling the growth of thismarket. The European region is the second chief industry. The Asia Pacific segmentis demonstrating the fastest developing region in this market. The industry will show steady development in the Middle East and Africa region in the forecast period.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/body-sensors-market-1065

 

Industry Updates:

Apr 2018Tufts University researchers have created new teeth sensors which could soon replace the traditional fitness trackers such as the Fitbit. The device measures just 2mm x 2mm. The tiny wireless device can be used connect to a smartphone which can then monitor and record an individual’s health. The device typicallyrecords a person’s food and beverage intake along with monitoring theirsalt, sugar and alcohol intake. The dental hygiene and fatigue can also supposedly be tracked. The device also additionally allows people to continue good nutrition. The teeth sensors make a central ‘bioresponsive’ layer, which can absorb chemicals and nutrients from food. The researchers also further state that the applications of this innovation can be spread to other uses as well.

 

Related Infographics Links

 

Cardiovascular Information System (CVIS) Market Research Report - Global Forecast till 2025

https://www.marketresearchfuture.com/infographics/cardiovascular-information-system-market

 

Cardiac Rehabilitation Devices Market Research Report- Global Forecast To 2023

https://www.marketresearchfuture.com/infographics/cardiac-rehabilitation-devices-market

 

Metabolic Biomarkers Testing Market is Increasing at a Successful CAGR of 11% During Forecast to 2023

Market Overview:

Biomarkers are molecules that help identify and indicate normal or abnormal processes in an individual’s body, which might be an indication of an underlying disease or condition. Different molecular types, such as proteins or hormones andDNA or genes can serve as biomarkers as they indicate something about an individual’s health condition. Metabolic biomarker testing involves the identification and quantification of metabolites within a biological system. The steps included in this process are identification, profiling, interpretation, and quantification.

Over the years, there has been an increasing demand for personalized medications in both Europe and the American region. This has been a vital factor behind the growth of the metabolic biomarkers testing market. Additionally, various other factors like the increasing support from the governmentwith favorable initiatives and research funding, the growing need for toxicology technologies, and wide-spread R&D activities across different sectors are all contributing to the growth of the market on a global scale. Recent developments in technology is a key strategy being implemented and executed by major market players to expand their global reach and fortify their product portfolio.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5613

Moreover, factors like increasing biotech and pharmaceutical R&D expenditure, need for precise diagnosis of diseases, and huge investments from government and private organizations are also driving the market growth of metabolic biomarkers testing. The global metabolic biomarker testing market is projected to expand at a CAGR of 11% during the forecast period between 2017-2023. However, lack of awareness concerning metabolic biomarkers and a small pool of professionals with the adequate skill and proficiency level are likely to hamper the market growth in the forthcoming years.

Market Segmentation

·         The global segmentation of Metabolic Biomarker Testing Market Overview is divided into indication, application, techniques, and end-user.

·         By indication, the market includes neurological disorders, inborn errors of metabolism, cardiovascular disorders, and others.

·         By techniques, the market includes detection and separation techniques.

·         Separation techniques are further narrowed down into capillary chromatography, liquid chromatography, and gas chromatography. The liquid chromatography market segment is divided into ultra-performance liquid chromatography and high-performance liquid chromatography.

·         By application, the market includes personalized medicine,toxicology testing,drug discovery or drug assessment,nutrigenomics,functional genomics, and others.

·         By end-user, the market segments into diagnostic tool companies,clinical laboratories,pharma & biotech companies,healthcare it/big data companies, and others.

Regional Analysis:

The geographical segmentation of metabolic biomarkers testing market covers four major regions: the Americas, Asia-Pacific, Europe, and the Middle East and Africa.

Due to the increasing applications of Next-Generation Sequencing procedures, the Americas is standing tall as the leading market player of metabolic biomarkers. Herein, the US is the most prominent country in terms of market share. The growing research activities initiated by a number of biological and pharmaceutical industries in this region is expected to propel the global metabolic biomarker testing market during the forecast period.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/metabolic-biomarker-testing-market-5613

The European region is the second largest market globally and is estimated to grow throughout the forecast period. This is primarily because of the presence of a vast pool of service providers for analytical equipment in this region and is expectedto steer the market in this region.  

Mendelian Disorder Testing Market is Growing at a Healthy CAGR of 6.54% During Forecast to 2023

 

 

Global Mendelian disorder testing Market   - Overview

The Mendelian disorder is genetic disorder in humans which arises due to mutation in a single gene. Mendelian disorder can be predicted with the help of a genograms. Hemophilia, thalassemia, color blindness, cystic fibrosis, sickle cell anemia,and phenylketonuria are the most common mendeliandisorders. Mendelian disorder is of four typesautosomal dominant, autosomal recessive, sex-linked dominant and sex-linked recessive. Genetic testing allows diagnosis of inherited diseases, it determines the changes in chromosomes, genes, proteins and metabolites. Some of the available genetic tests are: cell free foetal DNA testing, new-bornscreening, prenatal diagnosis, carrier testing, preimplantation genetic diagnosis, predictive and presymptomatic testing.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5500

Globally Mendelian Disorders Testing Market  Growth is estimated to grow at a rate of 6.5% during the forecast period.       

The market is going to continue with the same trends of growth during the forecast period2017-2023. According to U.S. Department of Health and Human Services, there are 70,000 to 80000 Americans affected by sickle cell disease,an inherited blood disorder. Thousands of new-borns are detected with beta thalassemia each year. Beta thalassemia is normallyaffects people from Central Asia, the Middle East, India,Southeast Asia, Mediterranean countries, and North Africa.Cystic fibrosis,a genetic disease occurs in 1 in 2,500 to 3,500 US new-borns. Therefore, the major factor driving the growth of the market is increasing prevalence of mendeliandiseases. Other factor include increasing technology advancement in genetic testing, increasing awareness in emerging economies for genetic testing, increasing simple, accessible procedureand various others.

Whereas, cost required for developing technology and inaccurate results may hinderthe growth of the market.

Key Players:

Some of key the players in the global mendelian disorders testing market are Bio-Rad Laboratories, Inc. (U.S.),Transgenomic Inc. (U.S.), ELITechGroup (France), Quest Diagnostics (U.S.), AutoGenomics (U.S.), Abbott Laboratories (U.S.),PerkinElmer Inc. (U.S.), Celera Group (U.S.), Roche Diagnostics (Switzerland), Applied Biosystems Inc. (U.S.), Thermo Fisher Scientific and others.

 

Global Mendelian disorder testing Market   - Competitive Analysis

There are many players of the Mendelian disorder testing Market Growth  but the existing players are strengthening their position in the industry by innovating technically advanced products. With well-established market, major companies like Abbott laboratories, ELITech Biomedical Systems, Thermo Fisher Scientific, Myriad Genetics Inc. and others acquire maximum market share.

Founded in 1900, Abbott laboratories discovers, develops, and markets a series of healthcare products. The company's Diagnostic Products include diagnostic systems and tests manufactured, marketed, and sold worldwide. In August 2016, Abbott introducedAlinity, a next-generation system used to carry out immunoassay, clinical chemistry, hematology, blood and plasma screening and molecular diagnostics. With the launch of Alinity portfolio, the company will be able to offer more efficiency and flexibility to doctors and scientists and help them improve decision-making and patient care.

ELITech Biomedical Systems a well-known world leader for the diagnosis of cystic fibrosis. ELITech’s Macroduct System is a simple and accurate sweat test system available. The firm is involved in product innovation such as its research and development department has developed Nanoduct, the miniature sweat analysis system for patients of any age. This patented Nanoduct enables doctors to intervene and treat this disease at an early stage. In April, 2018 ELITechGroup, entered into an agreement with R-Biopharm, a life science company to strengthen their positions in molecular infectious disease testing market.

Thermo Fisher Scientific an American multinational biotechnology product development company, founded in 2006 by the merger of Thermo Electron and Fisher Scientific. In September, 2015, Thermo Fisher launched targeted sequencing system S5 and S5 XL systems. Thermo Fisher concentrates on targeted sequencing applications in inherited disease, oncology, reproductive health, infectious disease, and forensics. The S5 and S5 XL are research-use only products but in future Thermo Fisher plans to register them with the US Food and Drug Administration. Along with the next generation sequencing systems, Thermo Fisher also launched 13 targeted AmpliSeq panels comprising 3,000 Mendelian disease genes. Thus extending their product line.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/mendelian-disorders-testing-market-5500

 

Qiagen a leading provider of molecular diagnostics is headquartered in Germany. QIAGEN announced new GeneReader NGS chemistry is ready launch and can be used with QIAGEN’s Digital NGS. Digital NGSuses Unique Molecular Index (UMI) technology that provides accurate quantification and detection of molecular variants. This technology is reliable and detects even the rarest of mutation. Thus fuelling its innovative solutions for better results.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Healthcare IT Market is Dynamically Rising at a Cognitive CAGR of 15% During Forecast to 2023

 

Market Synopsis:

 

The growth of the global healthcare IT market can be accredited to the introduction of a cascade of innovative technologies coupled with government support towards the modernization of the healthcare sector. The emergence of mobile health and telehealth services have further complemented the market growth as they have found relevance in emerging parts of the world. Multiple governments across the globe are encouraging the use of healthcare IT means in order to provide increased access to healthcare solutions.

 

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/5950

 

Healthcare Information Technology (IT) is the convergence of healthcare sector and information technology. It is a diverse field that applies IT in various aspects of the healthcare system to improve clinical and patient outcomes. The global Healthcare IT Market Companies is expected to expand at a CAGR of 15% over the forecast period of 2018-2023, predicts Market Research Future (MRFR) in an in-depth report.

 

 

Healthcare IT resources have been witnessing high demand due to augmenting demand for enhanced healthcare services. Healthcare IT solutions not only facilitate streamlining of operations and workflows but also aid in the maximization of output.

 

On the other hand, the growth of the global healthcare IT market might be deterred by high deployment cost and reluctance on the part of medical professionals to adopt advanced healthcare IT tools.

 

Competitive Landscape:

IBM (U.S.),Allscripts Healthcare Solutions, Inc. (U.S.),GE Healthcare (UK),Epic Systems Corporation (U.S.),McKesson Corporation, (U.S.),Oracle Corporation (U.S.),3M Health Information Systems (U.S.),Spok Inc. (U.S.),CSI Healthcare IT (U.S.),Koninklijke Philips N.V. (The Netherlands),Wolters Kluwer (Netherland),athenahealth, Inc. (U.S.),Syntel Inc. (U.S.),McKesson Corporation (U.S.),Cerner Corporation (U.S.),United Healthcare Group (U.S.),Cognizant Technology Solutions Corporation (U.S.),Anthelio Healthcare Solutions Inc. (U.S.),Lexmark Healthcare (U.S.),Orion Health (New Zealand),Conifer Health Solutions (U.S.),Infor, Inc. (U.S.),Kronos Incorporated (U.S.), and Dell Technologies (U.S.) are the key players in the global healthcare IT market.

 

Segmentation:

The global Healthcare IT Market Companies has been segmented based products and services, component, and end user.

 

By product and services, the global healthcare IT market has been segmented into healthcare provider solutions, healthcare payer solutions, HCIT outsourcing services, and others.

 

By component, the global healthcare IT market has been segmented into services, software,and hardware.

 

By end user, the global healthcare IT market has been segmentedinto healthcare providers, healthcare payers, research centers, third-party administrators and government institutions.

 

Regional Analysis:

By region, the global healthcare IT market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

 

The Americas is at the forefront of the global healthcare IT market. Deployment of modern healthcare technology, high healthcare expenditure and the presence of key players in the region are factors driving the market growth.

 

Europe is the second largest market for healthcare IT. Increasing healthcare expenditure, and augmenting need to curb healthcare costs along with the spreading trend of digitization among healthcare organizations are influencing the market growth.

 

APAC market is expected to exhibit the highest CAGR over the forecast period due to improving economic conditions in developing countries and measures taken to curtail soaring healthcare costs. Deep penetration of digitization in the region and government initiatives towards the modernization of thehealthcare sector are factors substantiating the growth of the market.

 

The MEA market is expected to expand at a steady pace due to factors such as increasing demand for healthcare services, high healthcare expenditure and improvement within the healthcare sector.

 

Browse More Details and TOC @ https://www.marketresearchfuture.com/reports/healthcare-it-market-5950

 

Industry Updates:

January 2019- The US FDA released the Digital Health Innovation Action Plan which is a stepping stone towards a more streamlined approval process for artificial intelligence and other digital healthcare products.

 

 

Pharmaceutical Contract Manufacturing Market IS Growing at a Soulful CAGR of 7.2% During Forecast to 2023

 

Market Insights:

 The pharmaceutical industry is experiencing a dynamic change. Pricing pressure, pipeline challenges, and emerging markets are redesigning the way companies operate. Pharmaceutical providers need to alter as well. Contract manufacturers that distinguish their abilities and offerings will be able to retain their customers and expand their business within the competitive market.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1532

The global pharmaceutical contract manufacturing market is expected to exhibit a strong 7.2% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR), rising to a valuation of more than USD 107 billion over the forecast period.

Competitive Analysis:                                                               

Leading players in the global Pharmaceutical Contract Manufacturing Market include Pharmaceutical Product Development LLC, Vetter, Patheon Inc., AbbVie Inc., Grifols International S.A., Lonza AG, Boehringer Ingelheim, and Catalant.

Segmentation:

By type, the global Pharmaceutical Contract Manufacturing Market Growth is segmented into active pharmaceutical ingredient manufacturing and finished dosage formulation manufacturing. The active pharmaceutical ingredient manufacturing segment holds the maximum share in the global pharmaceutical contract manufacturing market, accounting for more than 65% of the market in 2016. This is likely to remain the status quo in the global pharmaceutical contract manufacturing market in the coming years, as active pharmaceutical ingredients are likely to be one of the most researched topics in the pharma industry in the coming years. Regionally, China is likely to dominate the global active pharmaceutical ingredient manufacturing over the forecast period, while India is likely to emerge with a big share in the finished dosage formulations segment.

Regional Analysis:

The Americas hold the dominant share in the global pharmaceutical contract manufacturing market and are likely to remain the leading revenue generators over the forecast period due to the steady growth of the pharmaceutical contract manufacturing industry in the region over the last few years. The Americas market for pharmaceutical contract manufacturing is expected to reach a valuation of USD 40,041.5 million by 2023. The growing demand for high-tech pharmaceutical contract manufacturing such as biologics is likely to remain a key driver for the pharmaceutical contract manufacturing market in the Americas over the forecast period. Biologics are likely to remain a major part of the pharmaceutical contract manufacturing market in Americas over the forecast period, as the highly technical devices and technology required for biologics manufacturing and research is present widely in North America, especially the U.S. and Canada.

Europe holds the second largest share in the global pharmaceutical contract manufacturing market and is likely to remain a major revenue generator in the global pharmaceutical contract manufacturing market over the forecast period. The growing healthcare expenditure in Europe, especially in the developed economies in Western Europe, is likely to be a major driver for the pharmaceutical contract manufacturing market in the region over the forecast period. The increasing awareness about the profitability of the contract manufacturing business is also likely to lead to a growing demand from the pharmaceutical contract manufacturing market. Increasing government support for research and development avenues in the healthcare sector is likely to remain a key driver for the pharmaceutical contract manufacturing market in the region over the forecast period.

Access Full Report Details @ https://www.marketresearchfuture.com/sample_request/1532

Asia Pacific is likely to exhibit rapid growth in the global pharmaceutical contract manufacturing market, exhibiting a steady 7.7% CAGR over the forecast period from 2017 to 2023. The growing government support for healthcare research in Asia Pacific is likely to be a major driver for the pharmaceutical contract manufacturing market in Asia Pacific over the forecast period. The increasing pharmaceutical manufacturing industry in Asia Pacific is likely to lead to the formation of a strong pharmaceutical contract manufacturing industry in the region over the forecast period, with several players transferring their expertise in pharmaceutical manufacturing into contract manufacturing. The growing pharmaceutical manufacturing sector in China and India is likely to remain a major driver for the pharmaceutical contract manufacturing market in Asia Pacific over the forecast period.

The Middle East and Africa is not likely to exhibit significant growth in the global pharmaceutical contract manufacturing market in the coming years, as the region has been slow to adopt advances in pharmaceutical technology, resulting in a slow growth of the pharmaceutical manufacturing market. Lack of expertise in pharmaceutical manufacturing in the Middle East and Africa is likely to remain the major restraint for the pharmaceutical contract manufacturing market in the region over the forecast period.

Related Infographics Links:

Duloxetine API Market Research Report - Global Forecast till 2023

https://www.marketresearchfuture.com/infographics/duloxetine-api-market

 

Decorative High-Pressure Laminates Market Research Report—Forecast till 2023

https://www.marketresearchfuture.com/infographics/decorative-high-pressure-laminates-market

 

Microalbumin Test Market is Growing at a Promising CAGR of 5.1% During Forecast to 2023

 

Market Analysis:

The global microalbumin test market is projected to boom at an astral 5.1% CAGR over the assessment period (2017-2023). Microalbumin test is a kind of urine test which is used for diagnosing kidney diseases. Besides, it is also utilized for evaluating the risk of kidney problems amid patients that are diagnosed with diabetic retinopathy or diabetes. Microalbumin test, creatinine clearance tests and urine protein tests are widely utilized urine tests in diagnostic centers and hospitals. There are many devices and instruments used while conducting the microalbumin tests namely test strips, micro-cuvettes, control kit, reagent kit and urine analyzers.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5307

There are many factors that is driving the growth of themicroalbumin test market.Some of these factors as per the Market Research Future (MRFR) report include rising prevalence of renal dysfunction, diabetes and other forms of kidney problems, increasing R&D activities, advancements in technology in the medical device domain, rising geriatric population and demand for diagnostic and treatment for chronic diseases. On the contrary, factors such as test accuracy and soaring diagnostic medical device cost may hamper the growth of the microalbumin test market over the assessment period.

Key Players:

Randox Laboratories (U.K).), 77 Elektronika (Hungary), Sysmex (Japan), ACON Laboratories (US), OPTI Medical (U.S.), ARKRAY (Japan), URIT Medical (China), Abbott (U.S.), Roche (Switzerland), Nova Biomedical (U.S.), Siemens (Germany), Beckman Coulter (U.S.)

Market Segmentation:

Market Research Future report offers an all-inclusive segmental analysis of the Microalbumin Test Market Research  on the basis of product, indication and end user.

Based on product, it is segmented into test strips, micro-cuvettes, control kit, reagent kit, analyzer and others.

Based on indication, the microalbumin test market is segmented into high blood pressure, diabetes, kidney disease and others.

Based on end user, it is segmented into research laboratories, diagnostic laboratories, hospitals and others.

Regional Analysis:

Based on region, the microalbumin test market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will be at the vanguard over the assessment period owing to increasing prevalence of kidney diseases, accessibility of specialty services and increasing utilization of screening tests. Apart from this, the other factors that are driving the growth of the microalbumin test market in this region include the existence of key market players and rising need for diagnostic devices that are technologically advanced. Europe grabs the second largest share in the market owing to increasing use of point-care-testing devices, extensive R&D activities on medical devices and increasing healthcare expenditure. The healthcare expenditure in Germany was the maximum followed by France and the UK. The microalbumin test market in the APAC region is expected to have a favorable growth owing to accessibility of diagnostic services and rising prevalence of chronic kidney disease and diabetes. China and India are the leading economies here having an increasing occurrence of diabetes that is anticipated to expand in the near future. Also, accessibility of skilled healthcare experts is also driving the growth of the microalbumin test market. On the other hand, the factors that are driving the growth of the microalbumin test market in the Middle East and Africa include developing healthcare system and rising need for the specialty diagnostic services. The microalbumin test market in the Middle East is growing owing to sedentary lifestyle and lack of physical exercise and in Africa the factors that are driving the market growth include demand for diagnosis and treatment procedures for chronic diseases.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/microalbumin-test-market-5307

 

Feb 2019- Leading in-vitro diagnostic company, ERBA recently displayed its most recent invention Laura XL, a fully automated sediment and urine chemistry analyzer at the Dubai International Convention and Exhibition Centre. This device uses AI technology and digital microscopy for auto-recognizing 16 urine sediment elements. Presentations on the Laura XL was also held that highlighted on the various benefits of using this analyzer. The ERBA experts offered first-hand experience on this new device.